Glycemic Control With Triple Pathway Approach Through Empagliflozin, Linagliptin and Metformin Combination

Name: Glycemic Control With Triple Pathway Approach Through Empagliflozin, Linagliptin and Metformin Combination
License: Public Domain

Nabiqasim Industries (Pvt) Ltd

ClinicalTrials.gov · Datasets · License: Public Domain

diabetes mellitus, type 2 dm

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 448248
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.